Treatment of intrahepatic arteriovenous fistula in hepatocellular carcinoma with N-butyl-2-cyanoacrylate |
| |
摘 要: | Primary hepatocellular carcinoma (HCC) continues to be one of the most common malignancies with an incidence of approximately one million cases per year and a dismal prognosis; some authors have reported a median survival of 1 ~ 2 months after diagnosis. Although surgery remains the only hope for cure, few patients are candidates1,2].
|
Treatment of intrahepatic arteriovenous fistula in hepatocellular carcinoma with N-butyl-2-cyanoacrylate |
| |
Authors: | LI Yu-liang WANG Yong-zheng |
| |
Abstract: | Primary hepatocellular carcinoma (HCC) continues to be one of the most common malignancies with an incidence of approximately one million cases per year and a dismal prognosis; some authors have reported a median survival of 1 ~ 2 months after diagnosis. Although surgery remains the only hope for cure, few patients are candidates1,2]. |
| |
Keywords: | hepatocellular carcinoma arteriovenous fistula patients candidates surgery remains hope cure diagnosis median survival common malignancies incidence cases year prognosis Primary |
本文献已被 万方数据 等数据库收录! |